Congenital chylous ascites: a case report


  • Rajsree Sreedevi Department of Neonatology, Aster Medcity, Kochi, Kerala, India
  • Jose Paul Department of Neonatology, Aster Medcity, Kochi, Kerala, India
  • George Jose Department of Neonatology, Aster Medcity, Kochi, Kerala, India
  • Abdul Majeed Department of Paediatrics and neonatology, Aster Medcity, Dubai



Chylous ascites, Long chain fatty acids, Medium chain triglycerides, Newborn, Octreotide, Parenteral nutrition


Due to the rarity of congenital chylous ascites and the lack of standards in diagnosis and therapy, this disease constitutes a medical challenge and individual therapy seems to be extremely important. A late preterm newborn with antenatally diagnosed ascites was born and chylous ascites was diagnosed after feeds were started. The baby was managed initially with nil per oral, parenteral nutrition and octreotide, followed by adding MCT formula feeds. Considering the rarity of neonatal chylous ascites and the non-uniformity in management plans and follow up, more case reports need to be published. Also, MCT formula, the main stay of management has to be discontinued as soon as possible with gradual introduction into breast feeds or normal newborn formula milk as long chain fatty acids are essential for optimal brain growth in newborns. 


Mouravas V, Dede O, Hatziioannidis H, Spyridakis I, Filippopoulos A. Diagnosis and management of congenital neonatal chylous ascites. Hippokratia. 2012 Apr;16(2):175.

Bhatia C, Pratap U, Slavik Z. Octreotide therapy: a new horizon in treatment of iatrogenic chyloperitoneum. Archives of disease in childhood. 2001 Sep 1;85(3):234-5.

Cormack BE, Wilson NJ, Finucane K, West TM. Use of Monogen for pediatric postoperative chylothorax. The Annals of thoracic surger. 2004 Jan 1;77(1):301-5.

Romańska-Kita J, Borszewska-Kornacka MK, Dobrzańska A, Rudzińska I, Czech-Kowalska J, Wawrzoniak T. Congenital chylous ascites. Polish J Radiol. 2011 Jul;76(3):58.

McGibbon A, Chen GI, Peltekian KM, Van Zanten SV. An evidence-based manual for abdominal paracentesis. Digestive Disea Sciences. 2007 Dec 1;52(12):3307-15.

Pui MH, Yueh TC, Lymphoscintigraphy in chyluria, chyloperitoneum and chylothorax, J Nuclear Medicine, 1998;39(7):1292-6.

Karagol BS, Zenciroglu A, Gokce S, Kundak SS, Ipek MS. Therapeutic management of neonatal chylous ascites: report of a case and review of the literature. Acta Paediatrica, 2010;99(9):1307-10.

Yildirim AE, Altun R, Can S, Öcal S, Akbas E, Korkmaz M, Selçuk H, Yilmaz U. Idiopathic chylous ascites treated with total parenteral nutrition and octreotide. A case report and review of the literature. Eur J gastroenterol hepatol. 2011 Oct 1;23(10):961-3.

Widjaja A, Gratz KF, Ockenga J, Wagner S, Manns MP. Octreotide for therapy of chylous ascites in yellow nail syndrome. Gastroenterol. 1999 Apr 1;116(4):1017-8.

Vasko JS, Tapper RI. The surgical significance of chylous ascites. Archives of Surg. 1967 Sep 1;95(3):355-68.